looked in the drug addiction film "The Man with the Golden Arm."
patient suffering from neurotic depression told me how very ill she felt after stoppng her regimen of phenelzine and haloperidol to go on to lorazepam. The lorazepam made her excessively drowsy and she stopped it after a day or so but then she felt depressed and irritable and also described this feeling of cold and shivering.
This last symptom is quite reminiscent of the "cold turkey" reaction to the withdrawal of narcotics from the habituated, and the reaction followed so swiftly the disoontinuation of the drug that I wonder if it might not represent a genuine physical response to deprival of the drug rather than a purely psychological one We have been struck by the uniformity of this type of eruption, particularly in its distribution on the hands and bony prominences, the main features of which are scaling and thickening of the skin of the palms, soles, and sides of digits with atypical psoriasis-like plaques over the knees. The remainder of the rash is widely scattered over the body, being red and characterized by marginated scaling. In our opinion the clinical features produce an easily recognizable diagnostic picture.
These patients have been taking practolol for periods ranging from three weeks up to two years, with a mean duration of treatment of 10 months, before the onset of the rash. As this drug has now been available for over two years this latent period before the onset of the rash may be one explanation for the apparent increased frequency of the practolol-induced rashes that is our impression at present. We therefore consider it timely to draw the attention of the medical profession to this entity. The most marked effect on oral contraceptives would appear to come from the antibiotic rifampicin. This antibiotic is one of the recently introduced antituberculosis drugs and it has gained wide usage in many countries as it is very effective and easy to administer. Unfortunately, since it is given to ambulant patients many of these may also be taking oral contraceptives to prevent unwanted pregnancies during their treatment period. The first indication of this interaction came from Reimers et al.,2 who found that of 88 patients with pulmonary tuberculosis who were taking oral contraceptives in addition to rifampicin, 75% suffered from cycle disturbances and five became pregnant, whereas in another group, who received streptomycin, only 4% showed any cycle irregularity and there were no pregnancies.
Though other workers3 found no cycle disturbances or pill failure, it was felt by Reimers that rifampicin might influence the biogenesis and metabolism of the oestrogens and that this might lead to failure of action. Other antibiotics have also been shown to affect oestrogen metabolism, for ampicillin given to healthy mothers in the latter weeks of pregancy decreases the urinary oestriol levels by as much as 69% of the pretreatment level.4 It was felt that ampicillin also could give rise to unexpected complications with oral contraceptives by affecting the enterohepatic circulation of the oestrooens. This type of work has been confirmed by other workers.5
The second most common therapeutic group to affect the mechanism of action of oral contraceptives are the barbiturates. This could have been expected, as it was reported in 1968 by Levin8 that in animals chronic treatment with phenobarbitone could reduce the uterotropic effect of oestrogen and progestogens. Other workers" reported that barbiturates stimulate the metabolism, by enhancing the hydroxylation, of all steroids, and it was confirmed10 in vitro and in vivo in animals that the conversion of mestranol to erthinyloestradiol could be increased as much as three times by pretreatment with barbiturates.
